- Home
- LPCN vs OKYO Comparison
LPCN vs OKYO Comparison
Compare LPCN & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- OKYO
- Stock Information
- Founded
- LPCN 1997
- OKYO 2007
- Country
- LPCN United States
- OKYO United Kingdom
- Employees
- LPCN N/A
- OKYO N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LPCN Health Care
- OKYO Health Care
- Exchange
- LPCN Nasdaq
- OKYO Nasdaq
- Market Cap
- LPCN 36.8M
- OKYO 36.2M
- IPO Year
- LPCN N/A
- OKYO 2022
- Fundamental
- Price
- LPCN $4.87
- OKYO $1.06
- Analyst Decision
- LPCN Strong Buy
- OKYO Strong Buy
- Analyst Count
- LPCN 1
- OKYO 1
- Target Price
- LPCN $10.00
- OKYO $7.00
- AVG Volume (30 Days)
- LPCN 33.5K
- OKYO 22.2K
- Earning Date
- LPCN 11-07-2024
- OKYO 12-27-2024
- Dividend Yield
- LPCN N/A
- OKYO N/A
- EPS Growth
- LPCN N/A
- OKYO N/A
- EPS
- LPCN N/A
- OKYO N/A
- Revenue
- LPCN $7,922,926.00
- OKYO N/A
- Revenue This Year
- LPCN N/A
- OKYO N/A
- Revenue Next Year
- LPCN N/A
- OKYO N/A
- P/E Ratio
- LPCN N/A
- OKYO N/A
- Revenue Growth
- LPCN N/A
- OKYO N/A
- 52 Week Low
- LPCN $2.44
- OKYO $0.81
- 52 Week High
- LPCN $11.79
- OKYO $1.96
- Technical
- Relative Strength Index (RSI)
- LPCN 47.54
- OKYO 49.51
- Support Level
- LPCN $4.68
- OKYO $1.02
- Resistance Level
- LPCN $5.28
- OKYO $1.13
- Average True Range (ATR)
- LPCN 0.36
- OKYO 0.05
- MACD
- LPCN -0.01
- OKYO 0.00
- Stochastic Oscillator
- LPCN 44.44
- OKYO 41.67
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.